H
T. J. Hunter et al.
Special Topic
Synthesis
Ethyl (4R,5R,E)-4,5-Dihydroxy-6-((2R,4S,6R)-6-{2-[(4-methoxy-
HRMS (ESI): m/z calcd for [C29H34O9 + Na]+: 549.2101; found:
benzyl)oxy]ethyl}-2-phenyl-1,3-dioxan-4-yl)hex-2-enoate (23)
549.2082.
Into a 25 mL round bottom flask containing dienoate 22 (131 mg, 0.28
mmol) were added t-BuOH (2 mL), H2O (2 mL), K3Fe(CN)6 (277 mg,
0.84 mmol), K2CO3 (116 mg, 0.84 mmol), MeSO2NH2 (27 mg, 0.28
mmol), and (DHQD)2-PHAL (13 mg, 16.8 μmol). The mixture was
stirred at r.t. for 15 min and then cooled to 0 °C. To this solution was
added OsO4 (3.6 mg, 14 μmol) and the reaction mixture was stirred
vigorously at 0 °C overnight. The reaction was quenched with sat. aq
Na2SO3 (4 mL) at r.t. EtOAc (5 mL) was added to the reaction mixture,
and after separation of the layers, the aqueous phase was further ex-
tracted with EtOAc (2 × 10 mL). The combined organic layers were
washed with aq 2 N KOH (10 mL) to remove the methanesulfonamide
and brine, and then dried (anhyd Na2SO4). After removal of the sol-
vents in vacuo, flash chromatography on silica gel afforded 99 mg
(71%) of 23 as a clear oil; Rf = 0.16 (3:2 hexanes–EtOAc); [α]D +18.6 (c
1.2, CH2Cl2).
Ethyl (S,E)-5-Hydroxy-6-((2R,4S,6R)-6-{2-[(4-methoxyben-
zyl)oxy]ethyl}-2-phenyl-1,3-dioxan-4-yl)hex-2-enoate (syn-24)
Into a 10 mL round bottom flask fitted with a condenser and main-
tained under N2 were placed 23a (80 mg, 0.152 mmol),
Pd2(dba)3·CHCl3 (1.6 mg, 1.5 μmol), PPh3 (1 mg, 3.8 μmol), and THF
(1.5 mL). Et3N (63 μL, 0.46 mmol) and formic acid (17 μL, 0.46 mmol)
were added and the mixture was allowed to reflux for 3 h. The reac-
tion was cooled to r.t. and quenched with sat. aq NaHCO3 (2 mL). The
aqueous layer was extracted with Et2O (3 × 5 mL). The organic layer
was washed with brine (5 mL) and dried (anhyd Na2SO4). After re-
moval of the solvents in vacuo, flash chromatography on silica gel af-
forded syn-24 as a yellow oil (66 mg, 90%); Rf = 0.22 (3:2, hexanes–
EtOAc); [α]D +7.7 (c 1.0, CH2Cl2).
IR (neat): 3518, 3035, 2938, 2863, 1886, 1722, 1714, 1658, 1652,
1614, 1586, 1514, 1463, 1454, 1368, 1302, 1248, 1174 cm–1
.
IR (neat): 3478, 2914, 1713, 1660, 1613, 1586, 1547, 1514, 1463,
1454, 1304, 1100 cm–1
.
1H NMR (CDCl3, 500 MHz): δ = 7.41 (m, 2 H), 7.34 (m, 3 H), 7.26 (d, J =
9 Hz, 2 H), 6.98 (ddd, J = 15.5, 7.5, 7.5 Hz, 1 H), 6.86 (d, J = 8.5 Hz, 2 H),
5.90 (ddd, J = 15.5, 1.5, 1.5 Hz, 1 H), 5.56 (s, 1 H), 4.46 (d, J = 12 Hz, 1
H), 4.42 (d, J = 12 Hz, 1 H), 4.18 (q, J = 7 Hz, 2 H), 4.03–4.15 (m, 3 H),
3.79 (s, 3 H), 3.65 (ddd, J = 9.5, 8.5, 5 Hz, 1 H), 3.55 (ddd, J = 9.5, 5.5, 5.5
Hz, 1 H), 2.39 (m, 2 H), 1.92 (dddd, J = 14, 8.5, 5.5, 5.5 Hz, 1 H), 1.76–
1.86 (m, 2 H), 1.68 (ddd, J = 14.5, 2.5, 2.5 Hz, 1 H), 1.60 (ddd, J = 13,
2.5, 2.5 Hz, 1 H), 1.50 (ddd, J = 13, 11, 11 Hz, 1 H), 1.29 (q, J = 7 Hz, 3
H).
1H NMR (CDCl3, 300 MHz): δ = 7.41 (m, 2 H), 7.35 (m, 3 H), 7.26 (d, J =
9 Hz, 2 H), 6.96 (dd, J = 15.5, 5 Hz, 1 H), 6.87 (d, J = 9 Hz, 2 H), 6.14 (dd,
J = 15.5, 2 Hz, 1 H), 5.56 (s, 1 H), 4.45 (d, J = 11.5 Hz, 1 H), 4.45 (d, J =
11.5 Hz, 1 H), 4.20 (q, J = 7 Hz, 2 H), 4.19 (m, 2 H), 4.07 (dddd, J = 10.5,
7.5, 4, 2 Hz, 1 H), 3.93 (dddd, J = 9.5, 4.5, 2.5, 2.5 Hz, 1 H), 3.79 (s, 3 H),
3.65 (ddd, J = 9, 8, 5 Hz, 1 H), 3.56 (ddd, J = 9.5, 5.5, 5.5 Hz, 1 H), 1.92
(m, 2 H), 1.84 (m, 1 H), 1.77 (ddd, J = 15, 3, 3 Hz, 1 H), 1.62 (m, 1 H),
1.52 (ddd, J = 13, 11, 11 Hz, 1 H), 1.29 (t, J = 7 Hz, 3 H).
13C NMR (CDCl3, 125 MHz): δ = 166.3, 159.2, 146.8, 138.1, 130.5,
129.4, 129.0, 128.4, 126.0, 122.4, 113.8, 100.7, 80.7, 77.1, 73.8, 73.1,
72.7, 65.4, 60.5, 55.3, 38.6, 37.0, 36.0, 14.3.
HRMS (ESI): m/z calcd for [C28H36O8 + Na]+: 523.2308; found:
523.2329.
13C NMR (CDCl3, 75 MHz): δ = 166.3, 159.2, 145.0, 138.2, 130.5, 129.3,
128.9, 128.3, 126.0, 123.8, 113.8, 100.6, 77.4, 73.8, 72.7, 70.0, 65.5,
60.3, 55.3, 42.1, 40.2, 37.1, 36.0, 14.3.
HRMS (ESI): m/z calcd for [C28H36O7 + Na]+: 507.2359; found:
507.2348.
Ethyl (E)-3-{(4R,5R)-5-[((2R,4R,6R)-6-{2-[(4-Methoxyben-
zyl)oxy]ethyl}-2-phenyl-1,3-dioxan-4-yl)methyl]-2-oxo-1,3-diox-
olan-4-yl}acrylate (23a)
Ethyl 2-{(2R,4R,6R)-6-[((2R,4R,6R)-6-{2-[(4-Methoxyben-
zyl)oxy]ethyl}-2-phenyl-1,3-dioxan-4-yl)methyl]-2-phenyl-1,3-di-
oxan-4-yl}acetate (ent-syn-8)
Into a 10 mL volumetric flask containing diol 23 (90 mg, 0.18 mmol)
and pyridine (57 μL) was placed CH2Cl2 (2 mL). This mixture was
cooled to 0 °C and triphosgene (27 mg, 0.09 mmol) dissolved in
CH2Cl2 (1 mL) was added slowly using an addition funnel. The reac-
tion mixture was stirred for 1.5 h and quenched with sat. aq NH4Cl (4
mL). The layers were separated and the aqueous layer was extracted
with CH2Cl2 (3 × 5 mL). The combined organic layers were washed
with sat. aq NaHCO3 (10 mL), brine (10 mL), and dried (anhyd Na2SO4).
After removal of the solvents in vacuo, flash chromatography on silica
gel afforded 23a as a clear colorless oil (87 g, 92%); Rf = 0.11 (4:1 hex-
anes–EtOAc); [α]D +39.3 (c 1.7, CH2Cl2).
To a solution of alcohol syn-24 (75 mg, 0.155 mmol) in THF (1.5 mL) at
0 °C was added benzaldehyde (15 μL, 0.16 mmol), followed by KOt-Bu
(1.7 mg, 0.016 mmol). The solution was stirred for 15 min. The addi-
tion of benzaldehyde/KOt-Bu was repeated 3 more times and the re-
action was quenched with pH 7 phosphate buffer (1 mL) and diluted
with Et2O (3 mL). The layers were separated, and the aqueous layer
was extracted with Et2O (3 × 5 mL). The combined organic layers were
washed with brine, dried (anhyd Na2SO4), filtered, and concentrated
in vacuo. The crude product was purified by silica gel chromatogra-
phy to produce (syn,syn,syn)-dibenzylidene ent-syn-8 (58 mg) in 63%
yield as a clear oil; Rf = 0.26 (4:1 hexanes–EtOAc); [α]D +18.9 (c 0.9,
CH2Cl2).
IR (neat): 2920, 1810, 1716, 1668, 1615, 1586, 1560, 1516, 1456, 1248
cm–1
.
IR (neat): 2920, 2864, 1732, 1614, 1586, 1514, 1455, 1346, 1303,
1248, 1216, 1112, 1028 cm–1
.
1H NMR (CDCl3, 300 MHz): δ = 7.42 (m, 2 H), 7.36 (m, 3 H), 7.27 (d, J =
8.7 Hz, 2 H), 6.88 (d, J = 8.7 Hz, 2 H), 6.83 (dd, J = 15.6, 5.7 Hz, 1 H),
6.14 (dd, J = 15.6, 1.5 Hz, 1 H), 5.51 (s, 1 H), 5.14 (ddd, J = 7.2, 5.7, 1.5
Hz, 1 H), 4.63 (ddd, J = 6.6, 5.1, 5.1 Hz, 1 H), 4.48 (d, J = 11.7 Hz, 1 H),
4.43 (d, J = 11.7 Hz, 1 H), 4.20 (q, J = 7.2 Hz, 2 H), 4.02–4.18 (m, 2 H),
3.80 (s, 3 H), 3.66 (ddd, J = 9.3, 8.1, 5.1 Hz, 1 H), 3.57 (ddd, J = 11.1, 5.4,
5.4 Hz, 1 H), 2.08–2.18 (m, 2 H), 1.80–1.98 (m, 2 H), 1.58 (m, 2 H), 1.29
(t, J = 7.2 Hz, 3 H).
1H NMR (CDCl3, 300 MHz): δ = 7.49 (m, 4 H), 7.36 (m, 6 H), 7.27 (d, J =
8.7 Hz, 2 H), 6.87 (d, J = 8.7 Hz, 2 H), 5.59 (s, 1 H), 5.54 (s, 1 H), 4.50 (d,
J = 11.7 Hz, 1 H), 4.44 (d, J = 11.7 Hz, 1 H), 4.35 (dddd, J = 11.1, 6.6, 6.6,
2.1 Hz, 1 H), 4.18 (q, J = 7.2 Hz, 2 H), 4.02–4.18 (m, 3 H), 3.79 (s, 3 H),
3.69 (ddd, J = 9, 8.1, 5.1 Hz, 1 H), 3.60 (ddd, J = 9.6, 5.7, 5.7 Hz, 1 H),
2.76 (dd, J = 15.6, 7.2 Hz, 1 H), 2.54 (dd, J = 15.6, 6 Hz, 1 H), 2.16 (ddd,
J = 15.6, 7.2 Hz, 1 H), 1.64–2.00 (m, 5 H), 1.45–1.62 (m, 2 H), 1.28 (t, J =
7.2 Hz, 3 H).
13C NMR (CDCl3, 75 MHz): δ = 164.7, 159.0, 153.5, 139.1, 137.9, 130.3,
129.2, 128.7, 128.1, 125.8, 124.8, 113.6, 100.5, 79.4, 78.0, 73.6, 72.5,
71.9, 65.2, 60.9, 55.1, 37.7, 36.2, 35.8, 14.0.
© Georg Thieme Verlag Stuttgart · New York — Synthesis 2016, 48, A–K